AMS Capital’s STAAR Surgical STAA Stock Holding History

AMS Capital’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,305	Closed	-$639K	–	42
2018 Q3	$639K	Buy	+13,305	New	+$545K	0.53%	37

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AMS Capital's STAA Position: Q4 2018 in Review

AMS Capital sold out of STAAR Surgical (STAA) in Q4 2018, closing a stake of 13,305 shares — an estimated $639K sold.

AMS Capital first reported a position in STAA in Q3 2018 and held it in 1 quarter. The position peaked at $639K in Q3 2018. 181 funds tracked by Wall St. Rank hold STAA as of Q4 2018.

AMS Capital reported no remaining STAAR Surgical position as of Q4 2018 after selling out during the quarter.
AMS Capital sold 13,305 STAAR Surgical shares in Q4 2018, an estimated $639K.
AMS Capital first reported a position in STAAR Surgical in Q3 2018 and held it in 1 quarter.
AMS Capital's STAAR Surgical position peaked at $639K in Q3 2018.
181 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2018.

Based on AMS Capital's 13F filing for Q4 2018, filed 29 Jan 2019.